Chromadex Corp Stock Z Score
| CDXC Stock | USD 3.44 0.05 1.47% |
Chromadex | Z Score |
Chromadex Corp Company Z Score Analysis
Chromadex Corp's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
Chromadex Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Chromadex Corp is extremely important. It helps to project a fair market value of Chromadex Stock properly, considering its historical fundamentals such as Z Score. Since Chromadex Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Chromadex Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Chromadex Corp's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
| Competition |
In accordance with the company's disclosures, Chromadex Corp has a Z Score of 0.0. This is 100.0% lower than that of the Life Sciences Tools & Services sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.
Chromadex Corp Institutional Holders
Institutional Holdings refers to the ownership stake in Chromadex Corp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Chromadex Corp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Chromadex Corp's value.| Shares | Qube Research & Technologies | 2023-12-31 | 131.8 K | Millennium Management Llc | 2023-12-31 | 125.1 K | Royal Bank Of Canada | 2023-12-31 | 119 K | Cambridge Invest Research Advisors, Inc. | 2023-12-31 | 117.8 K | Connor Clark & Lunn Inv Mgmt Ltd | 2023-12-31 | 116.5 K | Northern Trust Corp | 2023-12-31 | 94.1 K | Bank Of New York Mellon Corp | 2023-12-31 | 86.1 K | Silverberg Bernstein Capital Management Llc | 2023-12-31 | 82.8 K | Squarepoint Ops Llc | 2023-12-31 | 61.9 K | Vanguard Group Inc | 2023-12-31 | 3 M | Tieton Capital Management, Llc | 2023-12-31 | 2.9 M |
Chromadex Fundamentals
| Return On Equity | -0.17 | ||||
| Return On Asset | -0.0642 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | (0.01) % | ||||
| Current Valuation | 235.74 M | ||||
| Shares Outstanding | 75.31 M | ||||
| Shares Owned By Insiders | 35.79 % | ||||
| Shares Owned By Institutions | 16.07 % | ||||
| Number Of Shares Shorted | 1.48 M | ||||
| Price To Earning | (19.51) X | ||||
| Price To Book | 10.19 X | ||||
| Price To Sales | 3.47 X | ||||
| Revenue | 83.57 M | ||||
| Gross Profit | 42.8 M | ||||
| EBITDA | (194 K) | ||||
| Net Income | (4.94 M) | ||||
| Cash And Equivalents | 16.87 M | ||||
| Cash Per Share | 0.25 X | ||||
| Total Debt | 3.28 M | ||||
| Debt To Equity | 0.22 % | ||||
| Current Ratio | 2.17 X | ||||
| Book Value Per Share | 0.38 X | ||||
| Cash Flow From Operations | 7.04 M | ||||
| Short Ratio | 2.32 X | ||||
| Earnings Per Share | (0.07) X | ||||
| Target Price | 6.47 | ||||
| Number Of Employees | 106 | ||||
| Beta | 1.99 | ||||
| Market Capitalization | 259.06 M | ||||
| Total Asset | 54.96 M | ||||
| Retained Earnings | (190.46 M) | ||||
| Working Capital | 28.91 M | ||||
| Current Asset | 16.55 M | ||||
| Current Liabilities | 9.59 M | ||||
| Net Asset | 54.96 M |
About Chromadex Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chromadex Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chromadex Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chromadex Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Chromadex Corp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Chromadex Corp's short interest history, or implied volatility extrapolated from Chromadex Corp options trading.
Pair Trading with Chromadex Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chromadex Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chromadex Corp will appreciate offsetting losses from the drop in the long position's value.Moving against Chromadex Stock
| 0.91 | ETON | Eton Pharmaceuticals Upward Rally | PairCorr |
| 0.78 | IPA | Immunoprecise Antibodies Financial Report 8th of July 2024 | PairCorr |
| 0.77 | EVOK | Evoke Pharma | PairCorr |
| 0.74 | CUE | Cue Biopharma Financial Report 14th of May 2024 | PairCorr |
| 0.73 | DVAX | Dynavax Technologies Financial Report 7th of May 2024 | PairCorr |
The ability to find closely correlated positions to Chromadex Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chromadex Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chromadex Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chromadex Corp to buy it.
The correlation of Chromadex Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chromadex Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chromadex Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chromadex Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Chromadex Corp Piotroski F Score and Chromadex Corp Valuation analysis. For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Chromadex Stock analysis
When running Chromadex Corp's price analysis, check to measure Chromadex Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chromadex Corp is operating at the current time. Most of Chromadex Corp's value examination focuses on studying past and present price action to predict the probability of Chromadex Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chromadex Corp's price. Additionally, you may evaluate how the addition of Chromadex Corp to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is Chromadex Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chromadex Corp. If investors know Chromadex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chromadex Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.07) | Revenue Per Share 1.114 | Quarterly Revenue Growth 0.01 | Return On Assets (0.06) | Return On Equity (0.17) |
The market value of Chromadex Corp is measured differently than its book value, which is the value of Chromadex that is recorded on the company's balance sheet. Investors also form their own opinion of Chromadex Corp's value that differs from its market value or its book value, called intrinsic value, which is Chromadex Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chromadex Corp's market value can be influenced by many factors that don't directly affect Chromadex Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chromadex Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chromadex Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chromadex Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.